LEADER 02355nam  2200553Ia 450 
001 9910826048103321
005 20240416230839.0
010   $a0-309-16859-7
010   $a0-309-50440-6
035   $a(CKB)111069351131834
035   $a(SSID)ssj0000099317
035   $a(PQKBManifestationID)11113484
035   $a(PQKBTitleCode)TC0000099317
035   $a(PQKBWorkID)10006838
035   $a(PQKB)10407788
035   $a(MiAaPQ)EBC3375425
035   $a(Au-PeEL)EBL3375425
035   $a(CaPaEBR)ebr10038699
035   $a(OCoLC)923256358
035   $a(EXLCZ)99111069351131834
100   $a20030617d2003      uy         0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aAdvancing prion science $eguidance for the National Prion Research Program, interim report /$fRick Erdtmann and Laura Sivitz, editors ; Committee on Transmissible Spongiform Encephalopathies: Assessment of Relevant Science, Medical Follow-Up Agency, Institute of Medicine of the National Academies
205   $a1st ed.
210   $aWashington, D.C. $cThe National Academies Press$d2003
215   $axx, 105 p
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a0-309-08744-9 
320   $aIncludes bibliographical references.
327   $aFront Matter -- Reviewers -- Preface -- Acknowledgments -- Contents -- Figures, Tables, and Boxes -- Abbreviations and Acronyms -- Executive Summary -- 1 Introduction -- 2 Prion Diseases and Their Challenges -- 3 Diagnostics for Transmissible Spongiform Encephalopathies -- 4 Research Recommendations for TSE Diagnostics -- 5 Prion Research Infrastructure -- 6 Risks to the U.S. Military -- Appendix Study Methods.
606   $aPrion diseases$xResearch$zUnited States
606   $aPrion diseases$xDiagnosis$zUnited States
615  0$aPrion diseases$xResearch
615  0$aPrion diseases$xDiagnosis
676   $a616.8/3
701   $aErdtmann$b Rick$01593715
701   $aSivitz$b Laura$01593716
712 02$aInstitute of Medicine (U.S.).$bCommittee on Transmissible Spongiform Encephalopathies: Assessment of Relevant Science.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910826048103321
996   $aAdvancing prion science$93913981
997   $aUNINA